Evidence map›Paper›PMID 41461552›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2025

[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B].

X Guo, P Y Fan, J Li, L X Wang, Y Dong, L L Cao, J G Yan, M Zhang, F S Wang

Abstract readEnglish Abstract
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [A real-world study of clinical cure in children with HBeAg-positive chronic hepatitis B from the Guangxi region].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

X GuoMedical School of Chinese PLA, Beijing 100853, China Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
P Y FanDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China Peking University 302 Clinical Medical School, Beijing 100191, China.
J LiDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
L X WangMedical School of Chinese PLA, Beijing 100853, China Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Y DongDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
L L CaoDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
J G YanDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
M ZhangDepartment of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
F S WangMedical School of Chinese PLA, Beijing 100853, China.

Funding

National Key Basic Research Program of China 2023YFC2308102National Natural Science Foundation of China 82130019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis B, ChronicAdolescentChildChild, PreschoolFemaleHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansInterferon-alphaMaleRetrospective StudiesTreatment OutcomeAntiviral AgentsHepatitis B e AntigensHepatitis B Surface AntigensInterferon-alpha

Identifiers

PMID41461552
PMCPMC12817046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.